Ft. Worth, Texas, Feb. 14, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — AppYea, Inc. (OTCPK:APYP, or the “Company”) is pleased to announce that is has entered into an exclusive CBD infused beverage licensing agreement with Prouty Company, Inc. (“ProutyCo”). The CBD infused beverage product line in development is based on four categories which are energy, focus, calm, and sleep. These are known as functional beverages and are a brand-new class of product.
CBD-infused beverages are expected to become a $260 million market by 2022. The global carbonated soft drinks market is projected to reach $605.6 Billion by 2025, according to a March 2018 report by Grand View Research, Inc. The global soft drink market, in another study, is forecast to grow at a CAGR of 5.62% through to 2021. CBD-based beverages are garnering all of the attention due to the recent headlines of Coca-Cola potentially getting involved in the space, but the reality is there are a number of CBD-based products that are already generating consistent and strong revenues on a daily basis. The CBD product market is already a $1 billion market and has staying power and is not anticipated to experience slowed growth at any point in the near future.
“We are very excited about our relationship with AppYea and look forward to providing a broad range of products and services to drive revenues across multiple channels and demographics,” said Phil Prouty, President and CEO of ProutyCo.
“We are excited about the revenue potential for this new line of CBD infused beverages and working with ProutyCo. These and other CBD based products will be sold and marketed under a new brand to be announced in the near future,” says Doug McKinnon, CEO of AppYea.
About Prouty Company, Inc.
Prouty Company Inc. is a global provider of products and services in the Telecommunications, Financial, Medical, Energy, Entertainment and Sports industries, and has holdings and expertise in a broad range of fields. With an emphasis on new technology development and product distribution, ProutyCo has holdings generating billions of dollars in sales annually and is growing at an exponential rate due to its continued innovation and diversity in leading-edge markets. (www.proutyco.com)
Please follow and like us:
The next big thing to hit the snack aisle could be marijuana.
Canadian pot company Aurora Cannabis said Wednesday it has hired snack-food tycoon Nelson Peltz as a strategic adviser — an announcement that sent its shares soaring as much as 15 percent.
Peltz, the CEO of hedge fund Trian Partners, may be a newcomer to the growing marijuana industry, but he’s long been an investor in the munchies. He’s the non-executive chairman of stoner-friendly fast-food restaurant Wendy’s, and has been the director of Heinz and Mondelez, the makers of Oreos.
Peltz, 76, is the second septuagenarian to team up with a pot producer inside of a month. Domestic diva Martha Stewart, 77, beat him to the punch with a deal last month to help Canada-based pot grower Canopy Growth develop new weed-based products for both people and pets.
Aurora chairman Michael Singer told CNBC Wednesday that the company is looking to sell “consumer package goods,” as well as weedy beverages, cosmetics, and pharmaceuticals.
Aurora has reportedly been in talks with Coca-Cola to develop beverages that use CBD, a non-psychotropic chemical found in marijuana that can be used to treat anxiety, depression, and cramps.
While Coke didn’t confirm or deny that it had been in talks with Aurora, the company said it was “closely watching the growth of non-psychoactive CBD as an ingredient in functional wellness beverages.”
The budding weed business has become a big draw for the ultra-wealthy as states, and entire countries in the case of Canada, legalize usage.
Peter Thiel’s medicinal cannabis company Tilray has more than doubled since its initial public offering, closing Tuesday at $72.15 a share.
The Aurora deal gives Peltz the option to buy nearly 20 million shares of the company at $7.74 – which could make him the second-largest owner, behind Vanguard.
The announcement sent the company’s shares soaring 15.5 percent in early-morning trading to a high $9.20 before moderating to about $8.80 a share.
Peltz’s hedge fund Trian declined to comment.
Source: New York Post
Please follow and like us: